I understand your dividend disappointment, but I expected no increase. The company took on $70m of debt to purchase Jundee, I'd rather them focus on paying that off first and happy to note over the last two months debt has decreased by $20m, great result! Annualised that equates to $120m or 20c per share - your extra dividend hasn't gone to waste...remember we should be looking into next year and the years ahead as today's results are only 1/5 the story.
- Forums
- ASX - By Stock
- NST
- Ann: Preliminary Final Report 30 June 2014
Ann: Preliminary Final Report 30 June 2014, page-11
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
|
|||||
Last
$13.95 |
Change
0.065(0.47%) |
Mkt cap ! $16.04B |
Open | High | Low | Value | Volume |
$14.01 | $14.11 | $13.94 | $7.175M | 512.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 3230 | $13.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.96 | 1720 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3514 | 13.950 |
8 | 1483 | 13.940 |
8 | 2087 | 13.930 |
6 | 2758 | 13.920 |
5 | 3854 | 13.910 |
Price($) | Vol. | No. |
---|---|---|
13.960 | 2972 | 17 |
13.970 | 2700 | 12 |
13.980 | 4495 | 13 |
13.990 | 4679 | 12 |
14.000 | 2323 | 10 |
Last trade - 11.21am 16/07/2024 (20 minute delay) ? |
Featured News
NST (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online